Is Ovid Therapeutics (OVID) One of the Best Fast Growing Penny Stocks to Buy According to Analysts? [Yahoo! Finance]
Ovid Therapeutics: Bullish Post-PIPE With 2 Differentiated CNS Moonshots [Seeking Alpha]
Ovid Therapeutics (NASDAQ:OVID) was upgraded by analysts at
Wall Street
Ovid Therapeutics (NASDAQ:OVID) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $4.00 price target on the stock.
Ovid Therapeutics (NASDAQ:OVID) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $2.00 price target on the stock.